ALNY fund manager activity
Alnylam Pharmaceuticals, Inc · Nasdaq. Reported by 9 tracked fund managers in their 13F filings, Q4 2014 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | No change | 3,500 | $1,391,775 | 0.00% | Feb 17, 2026 |
| Dodge & Cox Funds | Trimmed | 1,964,415 | $781,149,625 | 0.42% | Feb 13, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 39,622 | $15,755,688 | 0.06% | Feb 17, 2026 |
| Polen Capital Management | Sold out | — | — | 0.00% | Feb 12, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | New | 3,500 | $1,596,000 | 0.00% | Nov 14, 2025 |
| Dodge & Cox Funds | Trimmed | 2,321,230 | $1,058,480,880 | 0.57% | Nov 13, 2025 |
| Joel Greenblatt - Gotham Asset Management | Added | 28,135 | $12,829,560 | 0.06% | Nov 14, 2025 |
| Polen Capital Management | New | 693 | $316,008 | 0.00% | Nov 12, 2025 |
Newer quarters · Older quarters